Endotypic heterogeneity of chronic rhinosinusitis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Chronic rhinosinusitis (CRS) is one of the most common chronic respiratory diseases worldwide. CRS with polyps (CRS with polyps) is characterized by a high relapse rate, refractoriness to therapy, and is an unsolved problem in clinical rhinology. CRS is a heterogeneous disease with multiple clinical and immunological variants. The basis of the pathogenesis of CRS is chronic inflammation of the mucous membranes associated with pathological remodeling. This inflammation can occur with both high and low levels of type 2 immune response. Focusing on one type of inflammation (mainly T2) does not reflect the whole picture of pathogenesis. The emergence of new biological drugs targeting alarmins and specific cytokines requires a deep understanding of the involved immune pathways for adequate selection of therapy and prediction of response. There is a rapid increase in literature data on the role of individual cell populations and mediators, but there is no holistic understanding of their interactions and significance for different endotypes of CRS. Systematization of this knowledge will help to identify gaps in research, outline promising areas for the development of diagnostic biomarkers potentially suitable for targeted biological therapy, and improve the effectiveness of a personalized approach to the treatment of patients with CRS. This review is aimed to a comprehensive analysis and systematization of modern data on the immunological mechanisms of the pathogenesis of chronic rhinosinusitis. The article presents an overview of the scientific literature. A scientific search on the topic of immunogenesis of chronic rhinosinusitis was performed. The corresponding key terms and filters in the PubMed and Google Scholar search engines were used.

全文:

受限制的访问

作者简介

S. Krasilnikova

Privolzhsky Research Medical University

Email: mashkovasv@mail.ru
ORCID iD: 0000-0001-6153-6691

Cand. Sci. (Med.), Associate Professor, Department of Ear, Nose and Throat Diseases

俄罗斯联邦, Nizhny Novgorod

K. Gorbunova

Privolzhsky Research Medical University

Email: ksenya.gorbunova@mail.ru
ORCID iD: 0000-0003-4985-1546

Postgraduate Student, Department of Hospital Pediatrics

俄罗斯联邦, Nizhny Novgorod

T. Eliseeva

Privolzhsky Research Medical University

Email: eliseevati@yandex.ru
ORCID iD: 0000-0002-1769-3670

Dr. Sci. (Med.), Associate Professor, Professor at the Department of Hospital Pediatrics

俄罗斯联邦, Nizhny Novgorod

Vilya Bulgakova

Russian Scientific Center of Surgery named after Academician B.V. Petrovsky; Pirogov Russian National Research Medical University

编辑信件的主要联系方式.
Email: irvilbulgak@mail.ru
ORCID iD: 0000-0003-4861-0919

Dr. Sci. (Med.), Head of the Department of Scientific and Information Development, Research Institute of Pediatrics and Children’s Health, Research Clinical Center No. 2, Russian Scientific Center of Surgery named after Academician B.V. Petrovsky; Professor at the Department of Faculty Pediatrics, Faculty of Pediatrics, Pirogov Russian National Research Medical University

俄罗斯联邦, Moscow; Moscow

参考

  1. Fokkens W.J., Lund V.J., Hopkins C., et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. https://dx.doi.org/10.4193/Rhin20.600
  2. Hastan D., Fokkens W.J., Bachert C., et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216–23. https://dx.doi.org/10.1111/j.1398-9995.2011.02646.x
  3. Bachert C., Bhattacharyya N., Desrosiers M., Khan A.H. Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps. J Asthma Allergy. 2021;14:127–34. https://dx.doi.org/10.2147/JAA.S290424
  4. Li X., Li J., Xu X., et al. Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps. Expert Rev Clin Immunol. 2023;19(11):1419–25. https://dx.doi.org/10.1080/1744666X.2023.2246660
  5. Benjamin M.R., Stevens W.W., Li N., et al. Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting. J Allergy Clin Immunol Pract. 2019;7(3):1010–6. https://dx.doi.org/10.1016/j.jaip.2018.10.014. [Epub 2018/10/28].
  6. Van Zele T., Claeys S., Gevaert P., et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61(11):1280–9. https://dx.doi.org/10.1111/j.1398-9995.2006.01225.x
  7. Wang X., Sima Y., Zhao Y., et al. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors. J Allergy Clin Immunol. 2023;151(2):458–68. https://dx.doi.org/10.1016/j.jaci.2022.10.010
  8. Xie X., Xuan L., Zhao Y., et al. Diverse Endotypes of Chronic Rhinosinusitis and Clinical Implications. Clin Rev Allergy Immunol. 2023;65(3):420–32. https://dx.doi.org/10.1007/s12016-023-08976-y
  9. Savlevich E.L., Zurochka A.V., Kurbacheva O.M., et al. [Pleiomorphism of the cytokine profile in nasal polyp tissue depending on the phenotype of chronic rhinosinusitis with nasal polyps]. Vestn. Otorinolaringol. 2023;88(1):50–6. https://dx.doi.org/10.17116/otorino20228801150
  10. Kato A., Schleimer R.P., Bleier B.S. Mechanisms and pathogenesis of chronic rhinosinusitis. J. Allergy Clin. Immunol. 2022;149(5):1491–503. https://dx.doi.org/10.1016/j.jaci.2022.02.016
  11. Liao B., Cao P.P., Zeng M., et al. Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. Allergy. 2015;70(9):1169–80. https://dx.doi.org/10.1111/all.12667
  12. Krasilnikova S.V., Ovsyannikov D.Y., Eliseeva T.I., et al. Thymic Stromal Lymphopoietin as a Predictor of Hypertrophic Changes in the Nasal Mucosa in Children with Atopic Bronchial Asthma and Allergic Rhinitis. Pediatr. J named after G.N. Speransky. 2020;99(4):71–8. https://dx.doi.org/10.24110/0031-403x-2020-99-4-71-78
  13. Tyler M.A., Russell C.B., Smith D.E., et al. Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes. J Allergy Clin Immunol. 2017;139(3):1061–4e4. https://dx.doi.org/10.1016/j.jaci.2016.09.048
  14. Punnonen J., Yssel H., de Vries J.E. The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. Allergy Clin Immunol. 1997;100(6 Pt. 1):792–801. https://dx.doi.org/10.1016/s0091-6749(97)70276-8
  15. Krasilnikova S.V., Krestova E.I., Eliseeva T.I., et al. Inflammatory mediators in nasal secretion in patients with bronchial asthma and allergic rhinitis with or without polyposis and hypertrophic sinonasal mucosa. Explorat Med. 2025. https://dx.doi.org/10.37349/emed.2025.1001306
  16. Merlo L.M.F., DuHadaway J.B., Montgomery J.D., et al. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses. Front Immunol. 2020;11:1861. https://dx.doi.org/10.3389/fimmu.2020.01861
  17. Krasil’nikova S.V., Eliseeva T.I., Tush E.V., et al. Features of local inflammation of nasal mucosa in children with bronchial asthma. Rus Otorhinolaryngol. 2020;19(3):22–30. https://dx.doi.org/10.18692/1810-4800-2020-3-22-30
  18. Park S.J., Kim T.H., Jun Y.J., et al. Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3. J Allergy Clin Immunol. 2013;131(3):772–80. https://dx.doi.org/10.1016/j.jaci.2012.12.671
  19. Hao D., Wu Y., Li P., et al. An Integrated Analysis of Inflammatory Endotypes and Clinical Characteristics in Chronic Rhinosinusitis with Nasal Polyps. J Inflamm Res. 2022;15:5557–65. https://dx.doi.org/10.2147/JIR.S377301
  20. Turner J.H., Chandra R.K., Li P., et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines. J Allergy Clin Immunol. 2018;141(5):1895–7e7. https://dx.doi.org/10.1016/j.jaci.2018.02.002
  21. Min J.Y., Kim J.Y., Sung C.M., et al. Inflammatory Endotypes of Chronic Rhinosinusitis in the Korean Population: Distinct Expression of Type 3 Inflammation. Allergy Asthma Immunol Res. 2023;15(4):437–50. https://dx.doi.org/10.4168/aair.2023.15.4.437
  22. Takabayashi T., Kato A., Peters A.T., et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2013;132(3):584–92e4. https://dx.doi.org/10.1016/j.jaci.2013.02.003
  23. Golebski K., Ros X.R., Nagasawa M., et al. IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation. NatCommun. 2019;10(1):2162. https://dx.doi.org/10.1038/s41467-019-09883-7
  24. Delemarre T., Bochner B.S., Simon H.U., Bachert C. Rethinking neutrophils and eosinophils in chronic rhinosinusitis. J. Allergy Clin Immunol. 2021;148(2):327–35. https://dx.doi.org/10.1016/j.jaci.2021.03.024
  25. Sima Y., Wang X., Zhang L. Interaction of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2024;24(1):25–31. https://dx.doi.org/10.1097/ACI.0000000000000956
  26. Bassiouni A., Chen P.G., Wormald P.J. Mucosal remodeling and reversibility in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2013;13(1):4–12. https://dx.doi.org/10.1097/ACI.0b013e32835ad09e
  27. Van Bruaene N., Perez-Novo C., Van Crombruggen K., De Ruyck N., et al. Inflammation and remodelling patterns in early stage chronic rhinosinusitis. Clin Exp Allergy. 2012;42(6):883–90. https://dx.doi.org/10.1111/j.1365-2222.2011.03898.x
  28. Meng J., Zhou P., Liu Y., et al. The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling. PLoS One. 2013;8(12):e82373. https://dx.doi.org/10.1371/journal.pone.0082373
  29. Samitas K., Carter A., Kariyawasam H.H., Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited. Allergy. 2018;73(5):993–1002. https://dx.doi.org/10.1111/all.13373
  30. Wang M., Sun Y., Li C., et al. Eosinophils Correlate with Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis with Nasal Polyps. ORL. J Otorhinolaryngol Relat Spec. 2022;84(1):70–80. https://dx.doi.org/10.1159/000516847
  31. Li X., Huang J., Chen X., et al. IL-19 induced by IL-13/IL-17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP-9 expression via ERK/NF-kappaB signaling pathway. Clin Transl Allergy. 2021;11(1):e12003. https://dx.doi.org/10.1002/clt2.12003
  32. Hamilton D.W. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal. 2008;2(1–2):9–17. https://dx.doi.org/10.1007/s12079-008-0023-5
  33. Krasilnikova S.V., Tush E.V., Frolov P.A., et al. Periostin as a Biomarker of Allergic Inflammation in Atopic Bronchial Asthma and Allergic Rhinitis (a Pilot Study). Sovrem Tekhnol. Med 2021;12(5):37–45. https://dx.doi.org/10.17691/stm2020.12.5.04
  34. Wang X., Zhang N., Bo M., et al. Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138(5):1344–53. https://dx.doi.org/10.1016/j.jaci.2016.05.041
  35. Nakayama T., Lee I.T., Le W., et al. Inflammatory molecular endotypes of nasal polyps derived from White and Japanese populations. J Allergy Clin Immunol. 2022;149(4):1296–308.e6. https://dx.doi.org/10.1016/j.jaci.2021.11.017
  36. Zurochka A.V., Egorov V.I., Kurbacheva O.M., et al. Analysis of the clinical course of chronic rhinosinusitis with nasal polyps (CRSWNP) and pathomorphological composition of nasal polyp tissue in patients living in different regions of the Russian Federation. Head and Neck Rus J. 2021;9(3). https://dx.doi.org/10.25792/hn.2021.9.3.15-24
  37. Xie X., Wang P., Jin M., et al. IL-1beta-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps. Nat Commun. 2024;15(1):9101. https://dx.doi.org/10.1038/s41467-024-53307-0
  38. Hirschberg A., Kiss M., Kadocsa E., et al. Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis. EurArch. Otorhinolaryngol. 2016;273(7):1779–88. https://dx.doi.org/10.1007/s00405-015-3816-1
  39. Gao Y.B., Zhang Y., Zhang L. Advance in epithelial-mesenchymal transition in chronic rhinosinusitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;54(3):231–6. https://dx.doi.org/10.3760/cma.j.issn.1673-0860.2019.03.015
  40. Van Bruaene N., Perez-Novo C.A., Basinski T.M., et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121(6):1435–41, 1441 e1–3. https://dx.doi.org/10.1016/j.jaci.2008.02.018
  41. Tomassen P., Vandeplas G., Van Zele T., et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–56e4. https://dx.doi.org/10.1016/j.jaci.2015.12.1324
  42. Zhong B., Du J., Liu F., et al. Hypoxia-induced factor-1alpha induces NLRP3 expression by M1 macrophages in noneosinophilic chronic rhinosinusitis with nasal polyps. Allergy. 2021;76(2):582–6. https://dx.doi.org/10.1111/all.14571
  43. Liu C., Wang K., Liu W., et al. ALOX15(+) M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2024;154(3):592–608. https://dx.doi.org/10.1016/j.jaci.2024.04.019
  44. Ефимова М.И., Красильникова С.В., Овсянников Д.Ю. и др. Влияние микробиоты слизистой оболочки носа на уровень общего иммуноглобулина E в сыворотке крови у детей с бронхиальной астмой. Педиатрия. Журнал им. Г.Н. Сперанского. 2020;99(2):56–63. [Efimova M.I., Krasilnikova S.V., Ovsyannikov D.Yu. et al. The influence of the microbiota of the nasal mucosa on the level of total immunoglobulin E in the blood serum of children with bronchial asthma. Pediatrics. Journal im. G.N. Speransky. 2020;99(2):56–63. (In Russ.)]. https://dx.doi.org/10.24110/0031-403X-2020-99-2-56-63
  45. Du K., Zhao Y., Zhang X., et al. Staphylococcus aureus lysate induces an IgE response via memory B cells in nasal polyps. JAllergy Clin Immunol. 2024;153(3):718–31 e11. https://dx.doi.org/10.1016/j.jaci.2023.10.033
  46. Vizcarra-Melgar J., Sanchez-Gomez S., Lopez-Gonzalez N., et al. Tissue eosinophil level as a predictor of control, severity, and recurrence of Chronic Rhinosinusitis with Nasal Polyps. Front Allergy. 2025;6:1549332. https://dx.doi.org/10.3389/falgy.2025.1549332
  47. Turner J.H., Li P., Chandra R.K. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention. Int Forum Allergy Rhinol. 2018;8(10):1175–83. https://dx.doi.org/10.1002/alr.22160
  48. Castillo Vizuete J.A., Sastre J., del Cuvillo Bernal A., et al. Asthma, Rhinitis, and Nasal Polyp Multimorbidities. Arch Bronconeumol. (English Edition). 2019;55(3):146–55. https://dx.doi.org/10.1016/j.arbr.2018.12.020
  49. Ho J., Bailey M., Zaunders J., et al. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy. 2015;45(2):394–403. https://dx.doi.org/10.1111/cea.12462
  50. Bachert C., Zhang N., Cavaliere C., et al. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145(3):725–39. https://dx.doi.org/10.1016/j.jaci.2020.01.020
  51. Boita M., Bucca C., Riva G., et al. Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps. J Immunol Res. 2016;2016:2643297. https://dx.doi.org/10.1155/2016/2643297
  52. Nemati S., Keihanian F., Saeidinia A., Bakhshaei M. Effect Of Bevacizumab On Growth Of Human Nasal Polyposis In Vitro; An Off-Label Use Of Anti-Angiogenic Agent For Nasal Polyposis Treatment. Drug Des Devel Ther. 2019;13:3383-9. https://dx.doi.org/10.2147/DDDT.S219724
  53. Ko D.Y., Shin J.M., Um J.Y., et al. Rapamycin inhibits transforming growth factor beta 1 induced myofibroblast differentiation via the phosphorylated-phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 2016;30(6):211–7. https://dx.doi.org/10.2500/ajra.2016.30.4389
  54. Maxfield A.Z., Landegger L.D., Brook C.D., et al. Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2018;158(1):181–6. https://dx.doi.org/10.1177/0194599817737967
  55. Sato T., Ikeda H., Murakami K., et al. Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis. Allergol Int. 2023;72(1):161–8. https://dx.doi.org/10.1016/j.alit.2022.08.006
  56. Park S.K., Jin Y.D., Park Y.K., et al. IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis. PLoS One. 2017;12(8):e0181806. https://dx.doi.org/10.1371/journal.pone.0181806
  57. Yang H.W., Park J.H., Shin J.M., et al. CHI3L1 on fibrinolytic system imbalance in chronic rhinosinusitis with nasal polyp. Front Immunol. 2024;15:1410948. https://dx.doi.org/10.3389/fimmu.2024.1410948
  58. Jo A., Choi T.G., Han J.Y., et al. Age-Related Increase of Collagen/Fibrin Deposition and High PAI-1 Production in Human Nasal Polyps. Front Pharmacol. 2022;13:845324. https://dx.doi.org/10.3389/fphar.2022.845324
  59. Cao P.P., Wang B.F., Norton J.E., et al. Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2022;150(2):467–76e1. https://dx.doi.org/10.1016/j.jaci.2022.02.
  60. Takabayashi T., Imoto Y., Sakashita M., et al. Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus. Allergol Int. 2017;66(4):594–602. https://dx.doi.org/10.1016/j.alit.2017.03.007
  61. Stein E., Schneider A.L., Harmon R., et al. Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype. Int Forum Allergy Rhinol. 2023;13(1):15–24. https://dx.doi.org/10.1002/alr.23042
  62. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210. https://dx.doi.org/10.1002/path.2277
  63. Ball S.L., Mann D.A., Wilson J.A., Fisher A.J. The Role of the Fibroblast in Inflammatory Upper Airway Conditions. Am J Pathol. 2016;186(2):225–33. https://dx.doi.org/10.1016/j.ajpath.2015.09.020
  64. Nonaka M., Ogihara N., Fukumoto A., et al. Nasal polyp fibroblasts produce MIP-3alpha in response to toll-like receptor ligands and cytokine stimulation. Rhinology. 2010;48(1):41–6. https://dx.doi.org/10.4193/Rhin09.019
  65. Seshadri S., Rosati M., Lin D.C., et al. Regional differences in the expression of innate host defense molecules in sinonasal mucosa. J Allergy Clin Immunol. 2013;132(5):1227–30e5. https://dx.doi.org/10.1016/j.jaci.2013.05.042
  66. Tan B.K., Klingler A.I., Poposki J.A., et al. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol. 2017;139(2):699–703.e7. https://dx.doi.org/10.1016/j.jaci.2016.06.063
  67. Sedaghat A.R., Phillips K.M. Chronic rhinosinusitis disease control: a review of the history and the evidence. Expert Rev Clin Immunol. 2023;19(8):903–10. https://dx.doi.org/10.1080/1744666X.2023.2229027
  68. Haloob N., Karamali K., Hopkins C. The Role of Biologics in the Treatment of Chronic Rhinosinusitis. BioDrugs. 2023;37(4):477–87. https://dx.doi.org/10.1007/s40259-023-00602-9
  69. Patel G.B., Kudlaty E.A., Guo A., et al. Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis. Allergy Asthma Proc. 2021;42(5):417–24. https://dx.doi.org/10.2500/aap.2021.42.210058
  70. Alska E., Laszczych D., Napiorkowska-Baran K., et al. Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives. J Clin Med. 2025;14(4). https://dx.doi.org/10.3390/jcm14041079
  71. Bousquet J., Shamji M.H., Anto J.M., et al. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report. Allergy. 2023;78(7):1758–76. https://dx.doi.org/10.1111/all.15740

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2025